You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cancer testis antigen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Carcinoma Trial (rVV-740CTA)

Withdrawn
  • Breast Carcinoma
  • rVV-740CTA
  • (no location specified)
Feb 5, 2020

Advanced Soft-tissue Sarcoma Trial in Shenzhen (NY-ESO-1 TCR-T)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • NY-ESO-1 TCR-T
  • Shenzhen, Guangdong, China
    Li Yu
Nov 17, 2022

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available
  • Castration-Resistant Prostatic Cancer
  • (no location specified)
Sep 11, 2023

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

dapted Strategy Including Magnetic Resonance Imaging and

Completed
  • Prostate Cancer
  • Prostate Adenocarcinoma
    • Ankara, Turkey
      Ankara University School of Medicine
    Sep 6, 2023

    Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA

    Recruiting
    • Prostatic Neoplasms
    • Radical prostatectomy (RP)
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Jul 14, 2023

    Prostate Cancer Trial in Tomsk (Whole body study and SPECT with [99mTc]Tc-BQ0413)

    Enrolling by invitation
    • Prostate Cancer
    • Whole body study and SPECT with [99mTc]Tc-BQ0413
    • Tomsk, Russian Federation
      TomskNRMC
    Oct 26, 2023

    Follow-up After Surgery for Testicular Cancer

    Recruiting
    • Testicular Cancer
    • +2 more
      • Rotterdam, Zuid-Holland, Netherlands
        Erasmus Medical Center
      Jan 3, 2023

      Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

      Not yet recruiting
      • Prostate Adenocarcinoma
      • +2 more
      • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
      • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Jan 4, 2023

      Prostate Cancer Trial in United States (PSMA-PET CT)

      Not yet recruiting
      • Prostate Cancer
      • PSMA-PET CT
      • Los Angeles, California
      • +3 more
      Jul 6, 2023

      Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

      Not yet recruiting
      • Small Cell Lung Cancer Extensive Stage
      • Large Cell Neuroendocrine Carcinoma of the Lung
      • LB2102
      • (no location specified)
      Jan 10, 2023

      Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

      Recruiting
      • Colorectal Cancer
      • +6 more
      • CEA-targeted CAR-T cells
      • Hangzhou, Zhejiang, China
      • +1 more
      Sep 18, 2023

      TNBC - Triple-Negative Breast Cancer Trial in Brussels (Ga-PSMA PET/CT)

      Recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Ga-PSMA PET/CT
      • Brussels, Belgium
        Institut Jules Bordet
      Sep 26, 2023

      Prostate Cancer Trial (Darolutamide Oral Tablet [Nubeqa])

      Not yet recruiting
      • Prostate Cancer
      • Darolutamide Oral Tablet [Nubeqa]
      • (no location specified)
      Jun 2, 2023

      RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)

      Recruiting
      • Cervical
        • Wuxi, Jiangsu, China
          Wuxi People's Hospital
        Jul 3, 2023

        Testicular Cancer Trial in Worldwide (cabazitaxel)

        Recruiting
        • Testicular Cancer
        • Copenhagen, Denmark
        • +4 more
        Jul 18, 2022

        Advanced Solid Tumor Trial in Nijmegen (PRECIOUS-01)

        Recruiting
        • Advanced Solid Tumor
        • Nijmegen, Gelderland, Netherlands
          Radboudumc
        Oct 26, 2022

        Prostate Cancer Trial in Leuven (68Ga-PSMA (HBED-CC) PET)

        Recruiting
        • Prostate Cancer
        • 68Ga-PSMA (HBED-CC) PET
        • Leuven, Belgium
          UZLeuven
        Nov 18, 2022

        Prostate Cancer, Prostate Inflammation, PSA Trial in Albany (Ibuprofen or Naproxen, PSA test)

        Recruiting
        • Prostate Cancer
        • +2 more
        • Ibuprofen or Naproxen
        • PSA test
        • Albany, New York
          Albany Medical Center
        Nov 29, 2022

        Lung Cancer, Small Cell Lung Carcinoma, Non Small Cell Lung Cancer Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T Infusion)

        Not yet recruiting
        • Lung Cancer
        • +2 more
        • iC9.GD2.CAR.IL-15 T Infusion
        • Chapel Hill, North Carolina
          Lineberger Comprehensive Cancer Center
        Nov 16, 2022

        Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Taiyuan (CEA-targeted CAR-T cells)

        Recruiting
        • Gastric Cancer
        • +6 more
        • CEA-targeted CAR-T cells
        • Taiyuan, Shanxi, China
        • +1 more
        Aug 24, 2023

        Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Wuhu (CEA-targeted CAR-T cells)

        Recruiting
        • Gastric Cancer
        • +7 more
        • CEA-targeted CAR-T cells
        • Wuhu, Anhui, China
          The First Affiliated Hospital of Wannan Medical College
        Nov 9, 2023

        Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)

        Recruiting
        • Malignancy
        • Al18F-PSMA-BCH PET/CT
        • Beijing, Chaoyang, China
          National Cancer Center/Cancer Hospital,Chinese Academy of Medica
        Mar 7, 2023

        Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

        Not yet recruiting
        • Posto Perative Hepatocellular Carcinoma
        • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
        • (no location specified)
        Feb 27, 2023

        Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

        Recruiting
        • Prostatic Neoplasms, Castration-Resistant
        • Radionuclide Therapy
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus Medical Center
        Jun 5, 2023